Royal Bank of Canada’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Buy
986,300
+932,439
+1,731% +$1.05M ﹤0.01% 3500
2025
Q1
$79K Buy
53,861
+20,101
+60% +$29.5K ﹤0.01% 4991
2024
Q4
$72K Buy
33,760
+1,669
+5% +$3.56K ﹤0.01% 5033
2024
Q3
$90K Buy
32,091
+3,077
+11% +$8.63K ﹤0.01% 4960
2024
Q2
$67K Sell
29,014
-15,707
-35% -$36.3K ﹤0.01% 5124
2024
Q1
$200K Sell
44,721
-18,088
-29% -$80.9K ﹤0.01% 4261
2023
Q4
$202K Buy
62,809
+6,362
+11% +$20.5K ﹤0.01% 4570
2023
Q3
$179K Buy
56,447
+7,473
+15% +$23.7K ﹤0.01% 4430
2023
Q2
$244K Buy
48,974
+4,104
+9% +$20.4K ﹤0.01% 4146
2023
Q1
$221K Buy
44,870
+2,962
+7% +$14.6K ﹤0.01% 4167
2022
Q4
$264K Sell
41,908
-1,396
-3% -$8.79K ﹤0.01% 4184
2022
Q3
$468K Sell
43,304
-186
-0.4% -$2.01K ﹤0.01% 3633
2022
Q2
$495K Sell
43,490
-3,429
-7% -$39K ﹤0.01% 3681
2022
Q1
$427K Sell
46,919
-18,066
-28% -$164K ﹤0.01% 3945
2021
Q4
$970K Sell
64,985
-29,052
-31% -$434K ﹤0.01% 3362
2021
Q3
$2.42M Buy
94,037
+971
+1% +$25K ﹤0.01% 2535
2021
Q2
$2.43M Buy
93,066
+2,275
+3% +$59.3K ﹤0.01% 2554
2021
Q1
$3.21M Buy
90,791
+47,756
+111% +$1.69M ﹤0.01% 2286
2020
Q4
$1.09M Buy
43,035
+1,814
+4% +$45.8K ﹤0.01% 2969
2020
Q3
$1.55M Sell
41,221
-12,971
-24% -$489K ﹤0.01% 2527
2020
Q2
$2.32M Buy
54,192
+15,895
+42% +$681K ﹤0.01% 2185
2020
Q1
$744K Buy
38,297
+1,349
+4% +$26.2K ﹤0.01% 2869
2019
Q4
$960K Buy
36,948
+6,731
+22% +$175K ﹤0.01% 2949
2019
Q3
$824K Buy
30,217
+7,241
+32% +$197K ﹤0.01% 2984
2019
Q2
$617K Buy
22,976
+5,591
+32% +$150K ﹤0.01% 3201
2019
Q1
$503K Sell
17,385
-407
-2% -$11.8K ﹤0.01% 3215
2018
Q4
$479K Buy
+17,792
New +$479K ﹤0.01% 3163